nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—TYMS—Paclitaxel—Docetaxel—melanoma	0.0157	1	CbGdCrCtD
Pralatrexate—Neoplasm malignant—Vemurafenib—melanoma	0.0132	0.0406	CcSEcCtD
Pralatrexate—FPGS—retina—melanoma	0.0093	0.107	CbGeAlD
Pralatrexate—Pain in extremity—Vemurafenib—melanoma	0.00821	0.0251	CcSEcCtD
Pralatrexate—FPGS—skin of body—melanoma	0.00817	0.0943	CbGeAlD
Pralatrexate—SLC19A1—head—melanoma	0.008	0.0924	CbGeAlD
Pralatrexate—FPGS—mammalian vulva—melanoma	0.00745	0.086	CbGeAlD
Pralatrexate—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00739	0.0226	CcSEcCtD
Pralatrexate—DHFR—eye—melanoma	0.0061	0.0704	CbGeAlD
Pralatrexate—DHFR—retina—melanoma	0.00604	0.0698	CbGeAlD
Pralatrexate—Pharyngolaryngeal pain—Docetaxel—melanoma	0.00569	0.0174	CcSEcCtD
Pralatrexate—Laryngeal pain—Docetaxel—melanoma	0.00564	0.0173	CcSEcCtD
Pralatrexate—SLC19A1—lymph node—melanoma	0.0056	0.0647	CbGeAlD
Pralatrexate—Sepsis—Dactinomycin—melanoma	0.00554	0.017	CcSEcCtD
Pralatrexate—TYMS—skin of body—melanoma	0.00536	0.0619	CbGeAlD
Pralatrexate—FPGS—head—melanoma	0.00533	0.0615	CbGeAlD
Pralatrexate—Sepsis—Carmustine—melanoma	0.00519	0.0159	CcSEcCtD
Pralatrexate—TYMS—mammalian vulva—melanoma	0.00488	0.0564	CbGeAlD
Pralatrexate—DHFR—mammalian vulva—melanoma	0.00484	0.0559	CbGeAlD
Pralatrexate—Back pain—Vemurafenib—melanoma	0.00478	0.0146	CcSEcCtD
Pralatrexate—Cough—Vemurafenib—melanoma	0.00431	0.0132	CcSEcCtD
Pralatrexate—Liver function test abnormal—Dactinomycin—melanoma	0.00428	0.0131	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00418	0.0128	CcSEcCtD
Pralatrexate—Pancytopenia—Bleomycin—melanoma	0.00408	0.0125	CcSEcCtD
Pralatrexate—Liver function test abnormal—Carmustine—melanoma	0.00401	0.0123	CcSEcCtD
Pralatrexate—Hypokalaemia—Carmustine—melanoma	0.00395	0.0121	CcSEcCtD
Pralatrexate—Dehydration—Temozolomide—melanoma	0.0039	0.012	CcSEcCtD
Pralatrexate—Hypokalaemia—Temozolomide—melanoma	0.00382	0.0117	CcSEcCtD
Pralatrexate—Pancytopenia—Dactinomycin—melanoma	0.00381	0.0117	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00378	0.0116	CcSEcCtD
Pralatrexate—Neutropenia—Dactinomycin—melanoma	0.00375	0.0115	CcSEcCtD
Pralatrexate—FPGS—lymph node—melanoma	0.00373	0.0431	CbGeAlD
Pralatrexate—Pancytopenia—Carmustine—melanoma	0.00356	0.0109	CcSEcCtD
Pralatrexate—Neutropenia—Carmustine—melanoma	0.00351	0.0107	CcSEcCtD
Pralatrexate—Decreased appetite—Vemurafenib—melanoma	0.00351	0.0107	CcSEcCtD
Pralatrexate—TYMS—head—melanoma	0.00349	0.0404	CbGeAlD
Pralatrexate—Fatigue—Vemurafenib—melanoma	0.00348	0.0107	CcSEcCtD
Pralatrexate—DHFR—head—melanoma	0.00346	0.04	CbGeAlD
Pralatrexate—Constipation—Vemurafenib—melanoma	0.00345	0.0106	CcSEcCtD
Pralatrexate—Pancytopenia—Temozolomide—melanoma	0.00344	0.0105	CcSEcCtD
Pralatrexate—Neutropenia—Temozolomide—melanoma	0.00339	0.0104	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Temozolomide—melanoma	0.00337	0.0103	CcSEcCtD
Pralatrexate—Sepsis—Docetaxel—melanoma	0.00334	0.0102	CcSEcCtD
Pralatrexate—Body temperature increased—Vemurafenib—melanoma	0.00319	0.00977	CcSEcCtD
Pralatrexate—Asthenia—Vemurafenib—melanoma	0.00289	0.00887	CcSEcCtD
Pralatrexate—Pruritus—Vemurafenib—melanoma	0.00285	0.00874	CcSEcCtD
Pralatrexate—Pain in extremity—Docetaxel—melanoma	0.00279	0.00855	CcSEcCtD
Pralatrexate—Anaemia—Bleomycin—melanoma	0.00277	0.00848	CcSEcCtD
Pralatrexate—Diarrhoea—Vemurafenib—melanoma	0.00276	0.00846	CcSEcCtD
Pralatrexate—Leukopenia—Bleomycin—melanoma	0.00268	0.00821	CcSEcCtD
Pralatrexate—Cough—Bleomycin—melanoma	0.00261	0.00801	CcSEcCtD
Pralatrexate—Dehydration—Docetaxel—melanoma	0.00259	0.00795	CcSEcCtD
Pralatrexate—Anaemia—Dactinomycin—melanoma	0.00258	0.00791	CcSEcCtD
Pralatrexate—Liver function test abnormal—Docetaxel—melanoma	0.00258	0.00789	CcSEcCtD
Pralatrexate—Vomiting—Vemurafenib—melanoma	0.00257	0.00786	CcSEcCtD
Pralatrexate—Rash—Vemurafenib—melanoma	0.00254	0.00779	CcSEcCtD
Pralatrexate—Dermatitis—Vemurafenib—melanoma	0.00254	0.00779	CcSEcCtD
Pralatrexate—Back pain—Carmustine—melanoma	0.00253	0.00775	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00251	0.0077	CcSEcCtD
Pralatrexate—Leukopenia—Dactinomycin—melanoma	0.0025	0.00766	CcSEcCtD
Pralatrexate—TYMS—lymph node—melanoma	0.00245	0.0283	CbGeAlD
Pralatrexate—Oedema—Bleomycin—melanoma	0.00244	0.00749	CcSEcCtD
Pralatrexate—Back pain—Temozolomide—melanoma	0.00244	0.00749	CcSEcCtD
Pralatrexate—DHFR—lymph node—melanoma	0.00242	0.028	CbGeAlD
Pralatrexate—Anaemia—Carmustine—melanoma	0.00242	0.0074	CcSEcCtD
Pralatrexate—Nausea—Vemurafenib—melanoma	0.0024	0.00734	CcSEcCtD
Pralatrexate—Thrombocytopenia—Bleomycin—melanoma	0.00239	0.00733	CcSEcCtD
Pralatrexate—Leukopenia—Carmustine—melanoma	0.00234	0.00717	CcSEcCtD
Pralatrexate—Anaemia—Temozolomide—melanoma	0.00234	0.00715	CcSEcCtD
Pralatrexate—Anorexia—Bleomycin—melanoma	0.00233	0.00714	CcSEcCtD
Pralatrexate—Pancytopenia—Docetaxel—melanoma	0.00229	0.00701	CcSEcCtD
Pralatrexate—Oedema—Dactinomycin—melanoma	0.00228	0.00698	CcSEcCtD
Pralatrexate—Leukopenia—Temozolomide—melanoma	0.00226	0.00693	CcSEcCtD
Pralatrexate—Neutropenia—Docetaxel—melanoma	0.00225	0.00691	CcSEcCtD
Pralatrexate—Thrombocytopenia—Dactinomycin—melanoma	0.00223	0.00684	CcSEcCtD
Pralatrexate—Cough—Temozolomide—melanoma	0.0022	0.00675	CcSEcCtD
Pralatrexate—Dyspnoea—Bleomycin—melanoma	0.00218	0.00668	CcSEcCtD
Pralatrexate—Anorexia—Dactinomycin—melanoma	0.00217	0.00666	CcSEcCtD
Pralatrexate—Oedema—Carmustine—melanoma	0.00213	0.00654	CcSEcCtD
Pralatrexate—Decreased appetite—Bleomycin—melanoma	0.00212	0.00651	CcSEcCtD
Pralatrexate—Thrombocytopenia—Carmustine—melanoma	0.00209	0.0064	CcSEcCtD
Pralatrexate—Tachycardia—Carmustine—melanoma	0.00208	0.00638	CcSEcCtD
Pralatrexate—Oedema—Temozolomide—melanoma	0.00206	0.00632	CcSEcCtD
Pralatrexate—Anorexia—Carmustine—melanoma	0.00203	0.00623	CcSEcCtD
Pralatrexate—Epistaxis—Docetaxel—melanoma	0.00203	0.00621	CcSEcCtD
Pralatrexate—Thrombocytopenia—Temozolomide—melanoma	0.00202	0.00618	CcSEcCtD
Pralatrexate—Decreased appetite—Dactinomycin—melanoma	0.00198	0.00607	CcSEcCtD
Pralatrexate—Fatigue—Dactinomycin—melanoma	0.00197	0.00602	CcSEcCtD
Pralatrexate—Anorexia—Temozolomide—melanoma	0.00197	0.00602	CcSEcCtD
Pralatrexate—Body temperature increased—Bleomycin—melanoma	0.00193	0.00592	CcSEcCtD
Pralatrexate—Dyspnoea—Carmustine—melanoma	0.0019	0.00583	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Dactinomycin—melanoma	0.00186	0.00571	CcSEcCtD
Pralatrexate—Decreased appetite—Carmustine—melanoma	0.00185	0.00568	CcSEcCtD
Pralatrexate—Dyspnoea—Temozolomide—melanoma	0.00184	0.00563	CcSEcCtD
Pralatrexate—Constipation—Carmustine—melanoma	0.00182	0.00559	CcSEcCtD
Pralatrexate—Abdominal pain—Dactinomycin—melanoma	0.0018	0.00552	CcSEcCtD
Pralatrexate—Body temperature increased—Dactinomycin—melanoma	0.0018	0.00552	CcSEcCtD
Pralatrexate—Decreased appetite—Temozolomide—melanoma	0.00179	0.00549	CcSEcCtD
Pralatrexate—Fatigue—Temozolomide—melanoma	0.00178	0.00545	CcSEcCtD
Pralatrexate—Constipation—Temozolomide—melanoma	0.00176	0.0054	CcSEcCtD
Pralatrexate—Asthenia—Bleomycin—melanoma	0.00175	0.00537	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Carmustine—melanoma	0.00174	0.00534	CcSEcCtD
Pralatrexate—Pruritus—Bleomycin—melanoma	0.00173	0.0053	CcSEcCtD
Pralatrexate—Abdominal pain—Carmustine—melanoma	0.00169	0.00517	CcSEcCtD
Pralatrexate—Body temperature increased—Carmustine—melanoma	0.00169	0.00517	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Temozolomide—melanoma	0.00169	0.00517	CcSEcCtD
Pralatrexate—Asthenia—Dactinomycin—melanoma	0.00164	0.00501	CcSEcCtD
Pralatrexate—Abdominal pain—Temozolomide—melanoma	0.00163	0.00499	CcSEcCtD
Pralatrexate—Body temperature increased—Temozolomide—melanoma	0.00163	0.00499	CcSEcCtD
Pralatrexate—Back pain—Docetaxel—melanoma	0.00163	0.00498	CcSEcCtD
Pralatrexate—Diarrhoea—Dactinomycin—melanoma	0.00156	0.00478	CcSEcCtD
Pralatrexate—Vomiting—Bleomycin—melanoma	0.00155	0.00476	CcSEcCtD
Pralatrexate—Anaemia—Docetaxel—melanoma	0.00155	0.00476	CcSEcCtD
Pralatrexate—Rash—Bleomycin—melanoma	0.00154	0.00472	CcSEcCtD
Pralatrexate—Dermatitis—Bleomycin—melanoma	0.00154	0.00472	CcSEcCtD
Pralatrexate—Asthenia—Carmustine—melanoma	0.00153	0.00469	CcSEcCtD
Pralatrexate—Leukopenia—Docetaxel—melanoma	0.0015	0.00461	CcSEcCtD
Pralatrexate—Asthenia—Temozolomide—melanoma	0.00148	0.00453	CcSEcCtD
Pralatrexate—Cough—Docetaxel—melanoma	0.00147	0.00449	CcSEcCtD
Pralatrexate—Diarrhoea—Carmustine—melanoma	0.00146	0.00447	CcSEcCtD
Pralatrexate—Pruritus—Temozolomide—melanoma	0.00146	0.00447	CcSEcCtD
Pralatrexate—Nausea—Bleomycin—melanoma	0.00145	0.00445	CcSEcCtD
Pralatrexate—Vomiting—Dactinomycin—melanoma	0.00145	0.00444	CcSEcCtD
Pralatrexate—Rash—Dactinomycin—melanoma	0.00144	0.0044	CcSEcCtD
Pralatrexate—Diarrhoea—Temozolomide—melanoma	0.00141	0.00432	CcSEcCtD
Pralatrexate—Oedema—Docetaxel—melanoma	0.00137	0.0042	CcSEcCtD
Pralatrexate—Vomiting—Carmustine—melanoma	0.00136	0.00416	CcSEcCtD
Pralatrexate—Nausea—Dactinomycin—melanoma	0.00135	0.00415	CcSEcCtD
Pralatrexate—Rash—Carmustine—melanoma	0.00135	0.00412	CcSEcCtD
Pralatrexate—Dermatitis—Carmustine—melanoma	0.00134	0.00412	CcSEcCtD
Pralatrexate—Thrombocytopenia—Docetaxel—melanoma	0.00134	0.00411	CcSEcCtD
Pralatrexate—Tachycardia—Docetaxel—melanoma	0.00134	0.0041	CcSEcCtD
Pralatrexate—Vomiting—Temozolomide—melanoma	0.00131	0.00402	CcSEcCtD
Pralatrexate—Anorexia—Docetaxel—melanoma	0.00131	0.004	CcSEcCtD
Pralatrexate—Rash—Temozolomide—melanoma	0.0013	0.00398	CcSEcCtD
Pralatrexate—Dermatitis—Temozolomide—melanoma	0.0013	0.00398	CcSEcCtD
Pralatrexate—Nausea—Carmustine—melanoma	0.00127	0.00388	CcSEcCtD
Pralatrexate—Nausea—Temozolomide—melanoma	0.00122	0.00375	CcSEcCtD
Pralatrexate—Dyspnoea—Docetaxel—melanoma	0.00122	0.00374	CcSEcCtD
Pralatrexate—Decreased appetite—Docetaxel—melanoma	0.00119	0.00365	CcSEcCtD
Pralatrexate—Fatigue—Docetaxel—melanoma	0.00118	0.00362	CcSEcCtD
Pralatrexate—Constipation—Docetaxel—melanoma	0.00117	0.00359	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Docetaxel—melanoma	0.00112	0.00343	CcSEcCtD
Pralatrexate—Abdominal pain—Docetaxel—melanoma	0.00108	0.00332	CcSEcCtD
Pralatrexate—Body temperature increased—Docetaxel—melanoma	0.00108	0.00332	CcSEcCtD
Pralatrexate—Asthenia—Docetaxel—melanoma	0.000984	0.00301	CcSEcCtD
Pralatrexate—Pruritus—Docetaxel—melanoma	0.00097	0.00297	CcSEcCtD
Pralatrexate—Diarrhoea—Docetaxel—melanoma	0.000938	0.00287	CcSEcCtD
Pralatrexate—Vomiting—Docetaxel—melanoma	0.000872	0.00267	CcSEcCtD
Pralatrexate—Rash—Docetaxel—melanoma	0.000865	0.00265	CcSEcCtD
Pralatrexate—Dermatitis—Docetaxel—melanoma	0.000864	0.00265	CcSEcCtD
Pralatrexate—Nausea—Docetaxel—melanoma	0.000814	0.0025	CcSEcCtD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000354	0.000619	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GPAM—melanoma	0.000354	0.000619	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000352	0.000616	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HDAC6—melanoma	0.000349	0.00061	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PRKCA—melanoma	0.000348	0.000609	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—E2F1—melanoma	0.000346	0.000605	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ERCC2—melanoma	0.000345	0.000604	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PHGDH—melanoma	0.000343	0.0006	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—LUM—melanoma	0.000343	0.0006	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—PTEN—melanoma	0.00034	0.000595	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MAP2K1—melanoma	0.000339	0.000593	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—PRKCA—melanoma	0.000338	0.000593	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—E2F1—melanoma	0.000337	0.00059	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PIK3CD—melanoma	0.000337	0.000589	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HPSE—melanoma	0.000336	0.000589	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NOS2—melanoma	0.000336	0.000588	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDK2—melanoma	0.000333	0.000583	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NOTCH1—melanoma	0.000333	0.000583	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NPPA—melanoma	0.000331	0.000579	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—PRKCA—melanoma	0.00033	0.000578	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CUBN—melanoma	0.00033	0.000578	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN2B—melanoma	0.000328	0.000575	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CD80—melanoma	0.000326	0.000571	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—PCNA—melanoma	0.000326	0.00057	CbGpPWpGaD
Pralatrexate—FPGS—Disease—APC—melanoma	0.000326	0.00057	CbGpPWpGaD
Pralatrexate—FPGS—Disease—KIT—melanoma	0.000326	0.00057	CbGpPWpGaD
Pralatrexate—DHFR—Disease—VCAN—melanoma	0.000323	0.000565	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—FGF2—melanoma	0.000322	0.000564	CbGpPWpGaD
Pralatrexate—FPGS—Disease—EGF—melanoma	0.000322	0.000563	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3CG—melanoma	0.000321	0.000561	CbGpPWpGaD
Pralatrexate—DHFR—Disease—WNT5A—melanoma	0.00032	0.00056	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.00032	0.00056	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SDHD—melanoma	0.000319	0.000558	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CSPG4—melanoma	0.000319	0.000558	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—BSG—melanoma	0.000319	0.000558	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—PCNA—melanoma	0.000318	0.000557	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDK4—melanoma	0.000315	0.000551	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TERT—melanoma	0.000315	0.000551	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PPARG—melanoma	0.00031	0.000542	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GPAM—melanoma	0.000309	0.00054	CbGpPWpGaD
Pralatrexate—FPGS—Disease—BRAF—melanoma	0.000306	0.000536	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000302	0.000529	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MDM2—melanoma	0.000302	0.000528	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—E2F1—melanoma	0.000301	0.000528	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PLA2G6—melanoma	0.000301	0.000527	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDK2—melanoma	0.000298	0.000522	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—ERBB2—melanoma	0.000297	0.00052	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—PRKCA—melanoma	0.000295	0.000517	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000294	0.000515	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PIK3CB—melanoma	0.000293	0.000514	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CD4—melanoma	0.000293	0.000513	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDK2—melanoma	0.000291	0.000509	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PTGS2—melanoma	0.000291	0.000509	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MAP2K1—melanoma	0.000288	0.000504	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000288	0.000504	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000288	0.000504	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PIK3CD—melanoma	0.000286	0.000501	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—PCNA—melanoma	0.000284	0.000498	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—ATM—melanoma	0.000283	0.000495	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3CD—melanoma	0.000282	0.000493	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDK4—melanoma	0.000282	0.000493	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—ALB—melanoma	0.000278	0.000487	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDKN1B—melanoma	0.000275	0.000482	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDK4—melanoma	0.000275	0.000481	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TERT—melanoma	0.000275	0.000481	CbGpPWpGaD
Pralatrexate—FPGS—Disease—FGF2—melanoma	0.000274	0.00048	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000274	0.00048	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—RB1—melanoma	0.000274	0.000479	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CG—melanoma	0.000273	0.000477	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000272	0.000476	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—VCAN—melanoma	0.00027	0.000473	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PPARG—melanoma	0.000263	0.000461	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PLA2G6—melanoma	0.000262	0.000459	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CTNNB1—melanoma	0.00026	0.000455	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDK2—melanoma	0.00026	0.000455	CbGpPWpGaD
Pralatrexate—DHFR—Disease—GAB2—melanoma	0.000257	0.00045	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MDM2—melanoma	0.000256	0.000449	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDKN1A—melanoma	0.000254	0.000445	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PTEN—melanoma	0.000254	0.000444	CbGpPWpGaD
Pralatrexate—FPGS—Disease—ERBB2—melanoma	0.000253	0.000443	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FASN—melanoma	0.000252	0.00044	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.00025	0.000437	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PIK3CB—melanoma	0.000249	0.000437	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CD4—melanoma	0.000249	0.000436	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTGS2—melanoma	0.000247	0.000433	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—ATM—melanoma	0.000247	0.000432	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDK4—melanoma	0.000246	0.00043	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3CB—melanoma	0.000246	0.00043	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—RB1—melanoma	0.000245	0.000429	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PTGS2—melanoma	0.000243	0.000426	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CXCR4—melanoma	0.000242	0.000423	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FOXO4—melanoma	0.000242	0.000423	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HDAC2—melanoma	0.000242	0.000423	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000242	0.000423	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN2A—melanoma	0.000241	0.000421	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CD—melanoma	0.00024	0.00042	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—RB1—melanoma	0.000239	0.000418	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CD44—melanoma	0.000239	0.000418	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ALB—melanoma	0.000237	0.000414	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—VCAN—melanoma	0.000236	0.000413	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN1B—melanoma	0.000234	0.00041	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—TP53—melanoma	0.000232	0.000406	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP17A1—melanoma	0.000228	0.000399	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—STAT3—melanoma	0.000227	0.000397	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—NRAS—melanoma	0.000226	0.000396	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CTNNB1—melanoma	0.000221	0.000387	CbGpPWpGaD
Pralatrexate—DHFR—Disease—AKT3—melanoma	0.000221	0.000386	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MAPK3—melanoma	0.000217	0.000379	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN1A—melanoma	0.000216	0.000378	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTEN—melanoma	0.000216	0.000377	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GNA11—melanoma	0.000215	0.000377	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN2A—melanoma	0.000215	0.000377	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—RB1—melanoma	0.000214	0.000374	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN1B—melanoma	0.000213	0.000373	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PTEN—melanoma	0.000212	0.000372	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—IL6—melanoma	0.000212	0.000371	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MYC—melanoma	0.000211	0.000369	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—FASN—melanoma	0.000211	0.000369	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN2A—melanoma	0.00021	0.000368	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CB—melanoma	0.000209	0.000366	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MDM2—melanoma	0.000209	0.000366	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SLC5A5—melanoma	0.000207	0.000363	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTGS2—melanoma	0.000207	0.000362	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MAPK1—melanoma	0.000206	0.000361	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—EGFR—melanoma	0.000206	0.000361	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000204	0.000357	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CCND1—melanoma	0.000203	0.000356	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GNAQ—melanoma	0.0002	0.00035	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CD44—melanoma	0.0002	0.00035	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP17A1—melanoma	0.000199	0.000348	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN1A—melanoma	0.000197	0.000344	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ERBB4—melanoma	0.000195	0.000341	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—KRAS—melanoma	0.000195	0.000341	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN2B—melanoma	0.000193	0.000338	CbGpPWpGaD
Pralatrexate—FPGS—Disease—STAT3—melanoma	0.000193	0.000338	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NRAS—melanoma	0.000192	0.000337	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP1B1—melanoma	0.000192	0.000336	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN1B—melanoma	0.000191	0.000334	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GNA11—melanoma	0.000188	0.000329	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN2A—melanoma	0.000188	0.000329	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CD86—melanoma	0.000187	0.000327	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN1B—melanoma	0.000186	0.000326	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MAPK3—melanoma	0.000184	0.000322	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—FASN—melanoma	0.000184	0.000322	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MDM2—melanoma	0.000182	0.000319	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CCND1—melanoma	0.000182	0.000318	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGF1—melanoma	0.000181	0.000317	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SLC5A5—melanoma	0.000181	0.000317	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTEN—melanoma	0.000181	0.000316	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MYC—melanoma	0.000179	0.000314	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PIK3CA—melanoma	0.000179	0.000313	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CCND1—melanoma	0.000177	0.000311	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN1A—melanoma	0.000176	0.000308	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PDGFRA—melanoma	0.000175	0.000307	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MAPK1—melanoma	0.000175	0.000307	CbGpPWpGaD
Pralatrexate—FPGS—Disease—EGFR—melanoma	0.000175	0.000307	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CD44—melanoma	0.000175	0.000306	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GNAQ—melanoma	0.000175	0.000306	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PRKCA—melanoma	0.000174	0.000304	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ERCC2—melanoma	0.000172	0.000301	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN1A—melanoma	0.000172	0.000301	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MAP2K2—melanoma	0.00017	0.000297	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—MAPK3—melanoma	0.000168	0.000294	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP1B1—melanoma	0.000167	0.000293	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN1B—melanoma	0.000166	0.000291	CbGpPWpGaD
Pralatrexate—FPGS—Disease—KRAS—melanoma	0.000166	0.00029	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—HRAS—melanoma	0.000165	0.00029	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—MYC—melanoma	0.000163	0.000286	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TERT—melanoma	0.000161	0.000283	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HLA-A—melanoma	0.000161	0.000283	CbGpPWpGaD
Pralatrexate—DHFR—Disease—RAC1—melanoma	0.000161	0.000282	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—MAPK1—melanoma	0.00016	0.000279	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CCND1—melanoma	0.000159	0.000278	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—IL6—melanoma	0.000158	0.000277	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ABCB1—melanoma	0.000158	0.000277	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HIF1A—melanoma	0.000154	0.00027	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN1A—melanoma	0.000154	0.000269	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PIK3CA—melanoma	0.000152	0.000266	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MAPK3—melanoma	0.00015	0.000263	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3CA—melanoma	0.00015	0.000262	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—MAPK3—melanoma	0.000146	0.000256	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—AKT1—melanoma	0.000146	0.000256	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MYC—melanoma	0.000146	0.000255	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PRKCA—melanoma	0.000145	0.000255	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ERCC2—melanoma	0.000144	0.000252	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MAPK1—melanoma	0.000143	0.00025	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—MYC—melanoma	0.000142	0.000249	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HRAS—melanoma	0.000141	0.000246	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOS2—melanoma	0.00014	0.000246	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—MAPK1—melanoma	0.000139	0.000244	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOTCH1—melanoma	0.000139	0.000243	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ABCB1—melanoma	0.000138	0.000241	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CD80—melanoma	0.000136	0.000239	CbGpPWpGaD
Pralatrexate—DHFR—Disease—KIT—melanoma	0.000136	0.000238	CbGpPWpGaD
Pralatrexate—DHFR—Disease—APC—melanoma	0.000136	0.000238	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IL6—melanoma	0.000135	0.000236	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EGF—melanoma	0.000134	0.000235	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MAPK3—melanoma	0.000131	0.000229	CbGpPWpGaD
Pralatrexate—DHFR—Disease—BRAF—melanoma	0.000128	0.000224	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CA—melanoma	0.000127	0.000223	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MYC—melanoma	0.000127	0.000223	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PRKCA—melanoma	0.000127	0.000222	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ERCC2—melanoma	0.000126	0.00022	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MAPK1—melanoma	0.000125	0.000218	CbGpPWpGaD
Pralatrexate—FPGS—Disease—AKT1—melanoma	0.000124	0.000217	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—AKT1—melanoma	0.000122	0.000214	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MAP2K1—melanoma	0.00012	0.000211	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TP53—melanoma	0.00012	0.00021	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3CD—melanoma	0.00012	0.000209	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGF2—melanoma	0.000114	0.0002	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CG—melanoma	0.000114	0.000199	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PPARG—melanoma	0.00011	0.000192	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MDM2—melanoma	0.000107	0.000188	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ERBB2—melanoma	0.000106	0.000185	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TP53—melanoma	0.000105	0.000183	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3CB—melanoma	0.000104	0.000182	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—AKT1—melanoma	0.000104	0.000182	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CD4—melanoma	0.000104	0.000182	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTGS2—melanoma	0.000103	0.000181	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CD—melanoma	0.0001	0.000175	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CG—melanoma	9.94e-05	0.000174	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALB—melanoma	9.89e-05	0.000173	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN1B—melanoma	9.78e-05	0.000171	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PPARG—melanoma	9.59e-05	0.000168	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CTNNB1—melanoma	9.24e-05	0.000162	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN1A—melanoma	9.03e-05	0.000158	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTEN—melanoma	9.01e-05	0.000158	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CD—melanoma	8.74e-05	0.000153	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CB—melanoma	8.73e-05	0.000153	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTGS2—melanoma	8.65e-05	0.000151	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALB—melanoma	8.63e-05	0.000151	CbGpPWpGaD
Pralatrexate—DHFR—Disease—STAT3—melanoma	8.05e-05	0.000141	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NRAS—melanoma	8.03e-05	0.000141	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MAPK3—melanoma	7.69e-05	0.000135	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CB—melanoma	7.62e-05	0.000133	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTGS2—melanoma	7.55e-05	0.000132	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTEN—melanoma	7.54e-05	0.000132	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MYC—melanoma	7.48e-05	0.000131	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MAPK1—melanoma	7.32e-05	0.000128	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EGFR—melanoma	7.32e-05	0.000128	CbGpPWpGaD
Pralatrexate—DHFR—Disease—KRAS—melanoma	6.92e-05	0.000121	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTEN—melanoma	6.58e-05	0.000115	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3CA—melanoma	6.35e-05	0.000111	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HRAS—melanoma	5.88e-05	0.000103	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IL6—melanoma	5.63e-05	9.85e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CA—melanoma	5.32e-05	9.31e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—AKT1—melanoma	5.19e-05	9.08e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CA—melanoma	4.64e-05	8.13e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—AKT1—melanoma	4.35e-05	7.61e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—AKT1—melanoma	3.79e-05	6.64e-05	CbGpPWpGaD
